Literature DB >> 2065509

The Mediterranean Osteoporosis (MEDOS) Study questionnaire.

J Dequeker1, J Ranstam, J Valsson, B Sigurgevisson, E Allander.   

Abstract

The Mediterranean osteoporosis study (MEDOS) questionnaire was designed by a group of specialists in bone disease from Southern Europe (MAB Group) and the WHO Collaborating Centre for the Epidemiology of Rheumatic Conditions, assisted by experts from WHO in Geneva and from the European Foundation for Osteoporosis and Bone Disease. The purpose of the questionnaire was to identify putative risk factors for hip fracture in a retrospective case control study applied during a prospective study of the incidence of hip fracture in 14 regions of Europe.

Entities:  

Mesh:

Year:  1991        PMID: 2065509     DOI: 10.1007/BF02208034

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  1 in total

1.  Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire.

Authors:  J Dequeker; L Tobing; V Rutten; P Geusens
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

  1 in total
  17 in total

1.  Influence of age and body mass on the effects of vitamin D on hip fracture risk.

Authors:  J Ranstam; J A Kanis
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

2.  Site-specific variance in radius and tibia bone strength as determined by muscle size and body mass.

Authors:  Andrew William Frank; Megan Crystal Labas; James Duncan Johnston; Saija Annukka Kontulainen
Journal:  Physiother Can       Date:  2012       Impact factor: 1.037

3.  Hip fractures in France: the magnitude and perspective of the problem.

Authors:  C Baudoin; P Fardellone; B Thelot; R Juvin; V Potard; K Bean; J L Sebert
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

4.  Epidemiology of osteoporosis in Japan.

Authors:  T Hashimoto; K Sakata; N Yoshimura
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 5.  Epidemiology of hip fracture: the MEDOS study. Mediterranean Osteoporosis Study.

Authors:  G P Lyritis
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

6.  Twelve-month consumption of a polyphenol extract from olive (Olea europaea) in a double blind, randomized trial increases serum total osteocalcin levels and improves serum lipid profiles in postmenopausal women with osteopenia.

Authors:  R Filip; S Possemiers; A Heyerick; I Pinheiro; G Raszewski; M-J Davicco; V Coxam
Journal:  J Nutr Health Aging       Date:  2015-01       Impact factor: 4.075

7.  Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis.

Authors:  P Lips; C Cooper; D Agnusdei; F Caulin; P Egger; O Johnell; J A Kanis; U Liberman; H Minne; J Reeve; J Y Reginster; M C de Vernejoul; I Wiklund
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

8.  Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire.

Authors:  J Dequeker; L Tobing; V Rutten; P Geusens
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

9.  Quality of life, morbidity, and mortality after low trauma hip fracture in men.

Authors:  I Pande; D L Scott; T W O'Neill; C Pritchard; A D Woolf; M J Davis
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

10.  Association of physical exercise and calcium intake with bone mass measured by quantitative ultrasound.

Authors:  Yannis Dionyssiotis; Ioanna Paspati; Georgios Trovas; Antonios Galanos; Georgios P Lyritis
Journal:  BMC Womens Health       Date:  2010-04-07       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.